SCHEMBL3260259

SCHEMBL3260259

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3cc(C)ccc3C)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ LMNA P02545 4/20 0.44
▸ TSHR P16473 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ DRD2 P14416 3/20 0.42
▸ DRD4 P21917 3/20 0.42
▸ DRD3 P35462 3/20 0.42
▸ HTT P42858 2/20 0.42
▸ MAPT P10636 6/20 0.42
▸ GAA P10253 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ EGFR P00533 1/20 0.42
▸ KDR P35968 1/20 0.41
▸ TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162900 0.93 MAPT (0.44) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3258722 0.87 EGFR (0.46) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3175773 0.87 GAA (0.55) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL3162425 0.87 EGFR (0.53) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3170498 0.87 TSHR (0.41) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3172699 0.86 ALDH1A1 (0.51) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3160939 0.85 ALDH1A1 (0.52) ALDH1A1LMNATSHRSMN1; SMN2NPSR1
SCHEMBL3175718 0.85 DRD4 (0.51) ALDH1A1LMNAUSP2DRD2DRD4
SCHEMBL3175833 0.85 DRD4 (0.51) ALDH1A1LMNATSHRMEN1KMT2A
SCHEMBL3171920 0.85 ADORA1 (0.47) ALDH1A1GSK3BEGFRADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback